NCT05423873View on ClinicalTrials.gov

A Multi-Center, Open-label Study Evaluate the Efficacy and Tolerability of a Dual Skincare Regimen Treatment for Facial Hyperpigmentation and Photodamaged Skin in Patients Exposed to Extrinsic Factors of Aging

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

March 17, 2021

Primary Completion Date

February 10, 2022

Study Completion Date

February 10, 2022

Conditions
HyperpigmentationPhotodamaged SkinWrinkleFine Lines
Interventions
OTHER

Gentle Cleansing Lotion, Revision Skincare

Gentle cleansing lotion to be used by study participants twice daily

Trial Locations (3)

37203

Brian S. Biesman, M.D., Nashville

80111

About Skin, Greenwood Village

92075

Art of Skin MD, Solana Beach

All Listed Sponsors
lead

Revision Skincare

INDUSTRY

NCT05423873 - A Multi-Center, Open-label Study Evaluate the Efficacy and Tolerability of a Dual Skincare Regimen Treatment for Facial Hyperpigmentation and Photodamaged Skin in Patients Exposed to Extrinsic Factors of Aging | Biotech Hunter | Biotech Hunter